Need professional-grade analysis? Visit stockanalysis.com
$9.69B
N/A
193
N/A
Guangzhou Innogen Pharm Grp Co (2591) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at HKD20.12, down 3.73% from the previous close.
Over the past year, 2591 has traded between a low of HKD20.10 and a high of HKD57.25. The stock has lost 64.9% over this period. It is currently 64.9% below its 52-week high.
Guangzhou Innogen Pharm Grp Co has a market capitalization of $9.69B.
Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company's products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China.
Side-by-side comparison against top Healthcare peers.